KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition
KRAS 杂合性缺失促进 MAPK 依赖性胰腺导管腺癌发生并诱导对 MEK 抑制的治疗敏感性
期刊:Cancer Research
影响因子:12.5
doi:10.1158/0008-5472.CAN-23-2709
Sigrid K Fey #, Arafath K Najumudeen #, Dale M Watt, Laura M Millett, Catriona A Ford, Kathryn Gilroy, Rosalin J Simpson, Kathy McLay, Rosanna Upstill-Goddard, David Chang, William Clark, Colin Nixon, Joanna L Birch, Simon T Barry, Jennifer P Morton, Andrew D Campbell, Owen J Sansom